DNA SBC to Revenue
55.71%TTM
Retrieved:
DNA FY SBC/Revenue%
573.07%-60.71%
2019-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
DNA sbc to revenue history
Stock-based compensation as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.
| Period ending | SBC to Revenue |
|---|---|
| 47.9245% | |
| 49.4814% | |
| 91.4215% | |
| 404.1484% | |
| 511.737% | |
| 0.6209% | |
| 1.4229% |
Compare sbc to revenue
All DNA financial metrics · DNA stock overview · How to interpret financial metrics